News

3Q21 Earnings Release

São Paulo, November 11, 2021 - Alliar - Centro de Imagem Diagnósticos S.A. announces today its 3Q21 results.

Highlights:

  • Consistent figures for the fourth consecutive quarter, wtih revenue, EBITDA and net income growth.
  • Gross revenue totaled R$321.2 million, growth of 15.2% y/y.
  • Strong recovery in imaging exams, totaling R$269.4 million, growth of 21.3% y/y.
  • iDr continues to surpass its level of revenues, with growth of 36.1% y/y, reaching R$4.0 million in 3Q21.
  • Clinical Analysis (CA, excluding Covid tests) totaled R$41.8 million, an increase of 9.1% y/y.
  • Out-of-pocket exams revenue share, excluding Covid tests, reached 10.5%, growth of 10% versus 3Q20.
  • Adjusted EBITDA totaled R$77.3 million, growth of 36.9% y/y.
  • Net income of R$9.2 million, growth of R$11.1 million y/y,
  • Total net debt / LTM Adj. EBITDA reached 2.25x at the end of the period, a reduction of 50% versus 3Q20.
  • Operating cash generation of R$19.9 million in 3Q21; and robust cash position, in the amount of R$152.4 million at the end of the quarter.

Click here to access the Earnings Release.

Conference Call in Portuguese

November 12, 2021
12:30 p.m. (Local time)
10:30 a.m. (NY time)
Webcast: click here

IR Contact

Gabriel Rozenberg
IRO
Email:
ri@alliar.com